IMPACTT Project - The Supply and Delivery of COVID-19 Samples

A Contract Award Notice
by MEDICINES DISCOVERY CATAPULT

Source
Contracts Finder
Type
Framework (Products)
Duration
2 year
Value
£500K
Sector
HEALTH
Published
31 Aug 2021
Delivery
01 Aug 2021 to 31 Jul 2023
Deadline
30 Jul 2021 23:59

Related Terms

Location

Geochart for 1 buyers and 4 suppliers

1 buyer

4 suppliers

Description

The Medicines Discovery Catapult Ltd (MDC) has partnered with Oncimmune, who are experts in serological antibody profiling, on the IMPACTT project to create the largest severity based COVID biobank and data registry. The procurement was in two lots: • Lot 1 aimed to deliver a Phase 1 Discovery set of up to 2,000 samples; and • Lot 2 aimed to deliver a Phase 2 Validation set of up to 1,000 samples. This Framework Agreement is for a 24-month period, with an option to extend for a further 12 months, or until such time as the requisite number of samples (up to 3,000) have been collected (whether this is a shorter or a longer period). The total contract value is up to £500,000.00. The contract runs from August 2021.

Award Detail

1 Sera Laboratories (London)
  • Value: £500,000
2 Immunoserv (Cardiff)
  • Value: £500,000
3 Logical Biological (Maidstone)
  • Value: £500,000
4 Tissue Solutions (Glasgow)
  • Value: £500,000

CPV Codes

  • 33000000 - Medical equipments, pharmaceuticals and personal care products

Indicators

  • Contract is suitable for SMEs.

Reference

  • MEDDISC001-DN566774-11070604
  • CF 0b81f239-a873-414e-8e85-f74f351a683a

Domains